Target Name: MIR6862-2
NCBI ID: G102465907
Review Report on MIR6862-2 Target / Biomarker Content of Review Report on MIR6862-2 Target / Biomarker
MIR6862-2
Other Name(s): MicroRNA 6862-2 | hsa-mir-6862-2 | hsa-miR-6862-3p | hsa-miR-6862-5p | microRNA 6862-2

Discovery of MIR6862-2 as a Potential Drug Target for Cancer

MicroRNA 6862-2 (MIR6862-2) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. MIR6862-2 is a key regulator of cell proliferation and has been shown to play a role in the development and progression of various diseases, including cancer.

The discovery of MIR6862-2 as a potential drug target and biomarker has significant implications for the development of new treatments for cancer and other diseases. The identification of MIR6862-2 as a potential drug target suggests that targeting this molecule may be an effective way to treat diseases that are currently untreatable or have limited treatment options.

MIR6862-2 is a small non-coding RNA molecule that is approximately 200 amino acids in length. It is expressed in a variety of tissues and cells and has been shown to play a role in the regulation of cell proliferation, cell cycle progression, and apoptosis. MIR6862-2 is a key regulator of cell proliferation and has been shown to play a role in the development and progression of various diseases, including cancer.

One of the most significant findings related to MIR6862-2 is its role in the regulation of cell proliferation. MIR6862-2 has been shown to inhibit the activity of the oncogene transforming growth factor beta (TGF-??), which is a key regulator of cell proliferation. Inhibition of TGF-?? by MIR6862-2 has been shown to result in the inhibition of cell proliferation and the suppression of the growth of cancer cells.

Another finding related to MIR6862-2 is its role in the regulation of cell apoptosis. MIR6862-2 has been shown to play a role in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. MIR6862-2 has been shown to promote the formation of apoptotic cells and to regulate the apoptotic process.

MIR6862-2 has also been shown to play a role in the regulation of cell cycle progression. MIR6862-2 has been shown to promote the G1 phase of the cell cycle and to inhibit the S phase. The G1 phase is the phase of cell growth and development when cells are actively growing and dividing, while the S phase is the phase of cell growth and development when cells are replicating their DNA.

In conclusion, MIR6862-2 is a non-coding RNA molecule that has been shown to play a role in the regulation of cell proliferation, cell cycle progression, and apoptosis. The discovery of MIR6862-2 as a potential drug target and biomarker for various diseases, including cancer, has significant implications for the development of new treatments for these diseases. Further research is needed to fully understand the role of MIR6862-2 in the regulation of cell biology and to determine its potential as a drug target and biomarker.

Protein Name: MicroRNA 6862-2

The "MIR6862-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6862-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6863 | MIR6864 | MIR6865 | MIR6866 | MIR6867 | MIR6868 | MIR6869 | MIR6870 | MIR6871 | MIR6872 | MIR6873 | MIR6874 | MIR6875 | MIR6876 | MIR6877 | MIR6878 | MIR6879 | MIR6880 | MIR6881 | MIR6882 | MIR6883 | MIR6884 | MIR6885 | MIR6886 | MIR6887 | MIR6888 | MIR6889 | MIR6890 | MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702 | MIR7703 | MIR7704 | MIR7705 | MIR7706 | MIR7843 | MIR7844 | MIR7845 | MIR7846 | MIR7847 | MIR7848 | MIR7849 | MIR7850 | MIR7851 | MIR7854 | MIR7855 | MIR7856 | MIR7974 | MIR7975 | MIR7976 | MIR7977 | MIR802 | MIR8054 | MIR8055